Conaway C C, Hussain N S, Way B M, Fiala E S
American Health Foundation, Valhalla, NY 10595.
Mutat Res. 1991 Nov;261(3):197-207. doi: 10.1016/0165-1218(91)90068-w.
The secondary nitroalkanes 2-nitropropane, 2-nitrobutane, 3-nitropentane and nitrocyclopentane, as well as their anionic forms (nitronates); the primary nitroalkanes 1-nitropropane, 1-nitrobutane, and 1-nitropentane and their respective nitronates; the nitrocarbinols 2-nitro-1-propanol, 2-nitro-1-butanol, 3-nitro-2-butanol, and 3-nitro-2-pentanol and their respective nitronates; 2-methyl-2-nitropropane, and 2-nitroso-2-nitropropane were tested in the Ames Salmonella assay using strains TA98, TA100 and TA102. Nitronates of the secondary nitroalkanes 2-nitropropane, 2-nitrobutane, 3-nitropentane, and nitrocyclopentane were significantly mutagenic in Salmonella strains TA100 and TA102 at 10-80 mumoles/plate, but the parent compounds were mutagenic at only a single dose level or were not mutagenic at all in the same dose range. The primary nitroalkanes and the nitrocarbinols were not mutagenic, or only marginally so, at the concentrations tested. The nitronates of the primary nitroalkanes and the nitrocarbinols reprotonated too rapidly under the conditions of the assay for adequate evaluation of mutagenicity. 2-Methyl-2-nitropropane was not mutagenic in strains TA100 and TA102; 2-nitroso-2-nitropropane was also not mutagenic in strains TA100 and TA102, but induced an equivocal mutagenic response in TA98. The positive Salmonella mutation data for the nitronates of the secondary nitroalkanes studied correlate very well with the very slow rate of reprotonation of secondary nitroalkane nitronates at pH 7.7 (Conaway et al. (1991) Cancer Res., 51, 3143), and provide further evidence that nitronates of secondary nitroalkanes, rather than the neutral parent forms with which they may be in equilibrium, are the more proximate mutagenic species.
对仲硝基烷烃2-硝基丙烷、2-硝基丁烷、3-硝基戊烷和硝基环戊烷及其阴离子形式(硝酮酸酯);伯硝基烷烃1-硝基丙烷、1-硝基丁烷和1-硝基戊烷及其各自的硝酮酸酯;硝基甲醇2-硝基-1-丙醇、2-硝基-1-丁醇、3-硝基-2-丁醇和3-硝基-2-戊醇及其各自的硝酮酸酯;2-甲基-2-硝基丙烷和2-亚硝基-2-硝基丙烷,使用TA98、TA100和TA102菌株在艾姆斯沙门氏菌试验中进行了测试。仲硝基烷烃2-硝基丙烷、2-硝基丁烷、3-硝基戊烷和硝基环戊烷的硝酮酸酯在TA100和TA102沙门氏菌菌株中,在10 - 80微摩尔/平板时具有显著的致突变性,但母体化合物仅在单一剂量水平具有致突变性,或在相同剂量范围内根本没有致突变性。伯硝基烷烃和硝基甲醇在所测试的浓度下没有致突变性,或仅有轻微致突变性。伯硝基烷烃和硝基甲醇的硝酮酸酯在试验条件下重新质子化太快,无法充分评估其致突变性。2-甲基-2-硝基丙烷在TA100和TA102菌株中没有致突变性;2-亚硝基-2-硝基丙烷在TA100和TA102菌株中也没有致突变性,但在TA98中诱导了不确定的致突变反应。所研究的仲硝基烷烃硝酮酸酯的阳性沙门氏菌突变数据与仲硝基烷烃硝酮酸酯在pH 7.7时非常缓慢的重新质子化速率(Conaway等人,(1991年)《癌症研究》,51,3143)非常吻合,并进一步证明仲硝基烷烃的硝酮酸酯,而非它们可能处于平衡状态的中性母体形式,是更直接的致突变物种。